Every fall, millions of Americans sit down with a stack of Medicare mail and try to pick between two very different products.
The other costs real money every month and barely advertises.
The gap between them is where people get hurt.
Medicare Advantage, also called Part C, replaces Original Medicare with a private plan.
You often pay a $0 premium, but you inherit a network, prior authorizations, and a yearly cap on what you can be billed.
Supplements, known as Medigap, pay the gaps Original Medicare leaves behind.
You pay a monthly premium, but you keep any doctor in the country who takes Medicare.
The pitch for Advantage is easy to sell because the headline number is zero.
The catch is that nothing about health care stays zero once you actually use it.
Copays for specialists, hospital stays, and scans add up, and networks change every January.
A plan that covered your cardiologist this year can drop them next year, and you find out by mail.
You pay upfront, every month, whether you see a doctor or not.
There are no networks to check and no prior authorization for most routine care.
For someone with a chronic condition, that predictability is often worth more than the premium.
Here is the part that decides everything, and it has nothing to do with which plan is better on paper.
When you first enroll in Medicare Part B, you get a one-time window, usually six months, to buy any Medigap policy in your state without answering health questions.
Miss it, and insurers in most states can charge you more or reject you outright based on your medical history.
That single deadline is why agents push Advantage so hard.
Advantage plans are guaranteed issue during open enrollment, so they are easy to place.
Medigap is harder to sell and pays differently.
Follow the commission, and you will understand the advice you are getting.
Advantage plans are paid a set amount per member by the federal government, which means the plan keeps more when you use less.
That is not a conspiracy, it is the business model.
It shows up as narrower networks, more prior authorization, and denials that get overturned on appeal more often than they should.
None of this makes Advantage a bad choice.
If you are healthy, travel little, and want a low fixed cost, it can work well.
If you have ongoing conditions, see multiple specialists, or split time between states, the math usually tilts the other way.
The mistake is deciding based on the premium alone.
Talk to a broker who will show you both sides in writing, and ask specifically what happens to your doctors and your drugs next year.
Ask what your worst-case yearly bill looks like under each option, not just the best case.
The cheapest plan is only cheap until you need it.
The real scandal here is not that one product exists.
It is that a deadline most people have never heard of quietly locks them out of the option they might actually want.
If you are turning 65, treat that six-month window like a tax deadline, because it costs about as much to miss.
Final Thoughts
Read the fine print before someone reads it for you.